Evidence map›Paper›PMID 40343453›Full record

ArticleBasic research in cardiology2025

CD163

Wei Ni, Xiaofeng Ge, Yang Liu, Jingyu Chen, Lin Wang, Linjian Chen, Zhaokai Li, Peng Zhang, Shufen Huang, Junhui Xu and 8 more

Abstract read
PubMed Publisher
In one paragraph

Article in Basic research in cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Wei Ni *School of Medicine, Xiamen Cardiovascular Hospital, Xiamen University, Jinshan Road 2999, Xiamen, 361015, China.
Xiaofeng Ge *School of Medicine, Xiamen Cardiovascular Hospital, Xiamen University, Jinshan Road 2999, Xiamen, 361015, China.
Yang Liu *School of Medicine, Xiamen Cardiovascular Hospital, Xiamen University, Jinshan Road 2999, Xiamen, 361015, China.
Jingyu Chen *School of Medicine, Xiamen Cardiovascular Hospital, Xiamen University, Jinshan Road 2999, Xiamen, 361015, China.
Lin WangSchool of Medicine, Xiamen Cardiovascular Hospital, Xiamen University, Jinshan Road 2999, Xiamen, 361015, China.
Linjian ChenSchool of Medicine, Xiamen Cardiovascular Hospital, Xiamen University, Jinshan Road 2999, Xiamen, 361015, China.
Zhaokai LiSchool of Medicine, Xiamen Cardiovascular Hospital, Xiamen University, Jinshan Road 2999, Xiamen, 361015, China.
Peng ZhangSchool of Medicine, Xiamen Cardiovascular Hospital, Xiamen University, Jinshan Road 2999, Xiamen, 361015, China.
Shufen HuangSchool of Medicine, Xiamen Cardiovascular Hospital, Xiamen University, Jinshan Road 2999, Xiamen, 361015, China.
Junhui XuSchool of Medicine, Xiamen Cardiovascular Hospital, Xiamen University, Jinshan Road 2999, Xiamen, 361015, China.
Le ZhangSchool of Medicine, Xiamen Cardiovascular Hospital, Xiamen University, Jinshan Road 2999, Xiamen, 361015, China.
Xiabin FanSchool of Medicine, Xiamen Cardiovascular Hospital, Xiamen University, Jinshan Road 2999, Xiamen, 361015, China.
Gang WangSchool of Medicine, Xiamen Cardiovascular Hospital, Xiamen University, Jinshan Road 2999, Xiamen, 361015, China.
Wei HuangSchool of Medicine, Xiamen Cardiovascular Hospital, Xiamen University, Jinshan Road 2999, Xiamen, 361015, China.
Yuanchao YeDepartment of Medicine, University of Washington, 750 Republican Street, Seattle, WA, 98109, USA.
Jiancang ZhouSir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Qingchun East Road 3, Hangzhou, 310016, China.
Cuilian DaiSchool of Medicine, Xiamen Cardiovascular Hospital, Xiamen University, Jinshan Road 2999, Xiamen, 361015, China. daicl@xmu.edu.cn.
Binbin LiuSchool of Medicine, Xiamen Cardiovascular Hospital, Xiamen University, Jinshan Road 2999, Xiamen, 361015, China. liubinbin@xmu.edu.cn.ORCID 0000-0001-9454-6984

Funding

Fujian Provincial Health Technology Project 2021QNB021National Key Research and Development Program of China 2019YFE0113900Natural Science Foundation of Fujian Province 2024J011424Natural Science Foundation of Fujian Province 2024J011428Scientific Research Foundation of the Xiamen Human Resource Ministry for Returned Chinese Scholars 2023Xiamen Medical and Health Key Project 3502Z20204005Xiamen Medical and Health Project 3502Z20224ZD1182
6 · The paper itself

Abstract

Macrophage depletion exacerbates pressure overload-induced heart failure, but therapeutic translation is hindered by macrophage subset heterogeneity. The functional role of CD163

Indexed as

Antigens, CDAntigens, Differentiation, MyelomonocyticHeart FailureInterleukin-10MacrophagesMitochondria, HeartMyocytes, CardiacReceptors, Cell SurfaceVentricular Dysfunction, LeftVentricular Function, LeftAnimalsCD163 AntigenDisease Models, AnimalMaleMiceMice, Inbred C57BLAntigens, CDAntigens, Differentiation, MyelomonocyticCD163 AntigenIL10 protein, mouseInterleukin-10Receptors, Cell SurfaceCD163Dysfunctional mitochondriaHeart failureInterleukin-10Pressure overload

Identifiers

PMID40343453

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.